SOL-GEL TECHNOLOGIES LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7928 USD | +0.34% |
|
+7.25% | -28.25% |
Presenter SpeechGary Nachman (Analysts)Okay. Ready? Hey, everyone. I'm Gary Nachman. I'm the s...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Companyâs offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Calendar
08/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7901
USD
Average target price
6
USD
Spread / Average Target
+659.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.25% | 22.01M | |
| +10.61% | 115B | |
| +12.17% | 106B | |
| -4.58% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.01% | 17.56B | |
| -40.50% | 17.32B | |
| +6.50% | 14.03B | |
| +31.26% | 12.13B |
- Stock Market
- Equities
- SLGL Stock
- News Sol-Gel Technologies Ltd.
- Transcript : Sol-Gel Technologies Ltd. Presents at BMO 2020 Prescriptions for Success Healthcare Conference, Jun-23-2020 11
